Development
GE HealthCare Technologies Inc.
GEHC
$71.62
$0.070.10%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 217.99% | -65.88% | 13.52% |
| Total Depreciation and Amortization | -- | -- | -0.64% | 0.00% | -1.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -1,384.44% | 188.24% | 57.50% |
| Change in Net Operating Assets | -- | -- | -419.48% | -79.84% | 306.38% |
| Cash from Operations | -- | -- | -114.32% | -55.09% | 67.52% |
| Capital Expenditure | -- | -- | 51.05% | -85.71% | -4.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 84.25% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 25.00% | 121.05% | 56.82% |
| Cash from Investing | -- | -- | 68.42% | -180.00% | 19.49% |
| Total Debt Issued | -- | -- | -100.00% | -75.60% | 74,409.09% |
| Total Debt Repaid | -- | -- | 80.00% | -1,600.00% | 133.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 83.99% | 84.07% | -1,505.07% |
| Cash from Financing | -- | -- | -133.73% | 1,918.92% | 92.67% |
| Foreign Exchange rate Adjustments | -- | -- | -237.50% | -78.38% | 248.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -144.05% | -6.76% | 3,742.31% |